Natixis Advisors LLC Invests $232,000 in Pediatrix Medical Group, Inc. (NYSE:MD)

Natixis Advisors LLC purchased a new stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 17,721 shares of the company's stock, valued at approximately $232,000.

Other hedge funds have also recently bought and sold shares of the company. Quest Partners LLC boosted its stake in shares of Pediatrix Medical Group by 25.6% during the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company's stock valued at $35,000 after buying an additional 622 shares during the period. Everence Capital Management Inc. raised its holdings in shares of Pediatrix Medical Group by 7.5% during the fourth quarter. Everence Capital Management Inc. now owns 13,840 shares of the company's stock worth $182,000 after acquiring an additional 960 shares in the last quarter. Parkside Financial Bank & Trust increased its position in Pediatrix Medical Group by 36.1% in the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock worth $51,000 after purchasing an additional 1,040 shares during the last quarter. Quarry LP increased its position in Pediatrix Medical Group by 54.1% in the 3rd quarter. Quarry LP now owns 4,735 shares of the company's stock worth $55,000 after purchasing an additional 1,662 shares during the last quarter. Finally, AlphaQuest LLC lifted its holdings in shares of Pediatrix Medical Group by 65.9% during the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock valued at $66,000 after buying an additional 2,012 shares during the last quarter. 97.71% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. UBS Group increased their price objective on Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a "neutral" rating in a report on Friday, February 21st. StockNews.com upgraded shares of Pediatrix Medical Group from a "hold" rating to a "buy" rating in a report on Wednesday, January 22nd. Macquarie started coverage on shares of Pediatrix Medical Group in a research note on Monday, December 16th. They issued an "outperform" rating and a $18.00 price objective for the company. Finally, Truist Financial increased their target price on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a "hold" rating in a research report on Friday, February 21st. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $17.08.

Pediatrix Medical Group Stock Performance

NYSE:MD traded up $0.32 during midday trading on Wednesday, reaching $14.83. The stock had a trading volume of 501,596 shares, compared to its average volume of 835,774. The stock has a market capitalization of $1.27 billion, a P/E ratio of -12.36, a PEG ratio of 1.74 and a beta of 1.49. Pediatrix Medical Group, Inc. has a 1-year low of $6.62 and a 1-year high of $17.67. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. The firm's fifty day simple moving average is $14.44 and its 200-day simple moving average is $13.75.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings data on Thursday, February 20th. The company reported $0.49 EPS for the quarter, topping analysts' consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The business had revenue of $502.36 million for the quarter, compared to analyst estimates of $486.22 million. On average, equities research analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.